Are Peptides Steroids? The Actual Differences

The Short Answer

Peptides are not steroids. Not chemically, not mechanistically, not legally. A peptide is a short chain of amino acids, the same building blocks that make up every protein in your body. A steroid is a lipid molecule built on a four-ring carbon skeleton derived from cholesterol. Asking whether BPC-157 Explore PeRxBPC-157The Body Protection CompoundView peptide is a steroid is a bit like asking whether a sentence is a brick: they are made of different materials and do different jobs.

That said, the question deserves a better answer than a flat no, because the people asking it usually have a specific worry behind it. Some are asking whether peptides will do to their hormones what steroids do. Some want to know if a peptide prescription creates a legal problem the way possessing testosterone without a prescription does. Some compete in a tested sport and need to know whether "not a steroid" translates to "not banned." And a few have read that sermorelin Explore PeRxSermorelinThe Growth Hormone OptimizerView peptide or ipamorelin "boost growth hormone" and reasonably wonder whether that makes them a hormone drug in disguise.

Each of those has a different answer. The rest of this page works through them in order, from the chemistry up. The one place where the answer is genuinely uncomfortable is anti-doping, and we cover that plainly rather than burying it.

Chemistry: What Each Molecule Is

Start with structure, since everything else follows from it. A peptide is a chain of amino acids linked by peptide bonds, the same bond that holds proteins together. The only difference between a peptide and a protein is length: chains under roughly 50 amino acids are called peptides, longer ones are proteins. BPC-157 is 15 amino acids. Sermorelin is 29. Ipamorelin is 5. Insulin, for comparison, is 51 and sits right at the border. For a fuller walk through the biology, see our companion piece on what peptides are Read nextWhat Are Peptides? A Plain-English GuidePeptides are short chains of amino acids, and your body has been making them since before you were born. This is the definitional guide from a clinic that prescribes them: the chemistry without the textbook, the peptides you already have, how prescription peptides differ from the ones in face cream, and what actually happens between an intake form and a vial.Read article .

Anabolic steroids are a completely different chemical family. Every steroid shares a core of four fused carbon rings (three six-membered rings and one five-membered ring, the sterane skeleton), and the body builds all of its steroid hormones, testosterone included, from cholesterol. The DEA's own fact sheet on anabolic steroids describes them as drugs "with a basic steroid ring structure" whose chemical properties "are defined by their core four-ring structure and the various chemical modifications." Most anabolic steroids sold illicitly are synthetic derivatives of testosterone with small modifications to that ring system to change potency, oral availability, or how quickly the liver clears them.

Two consequences fall out of this structural difference. First, peptides are water-soluble and steroids are fat-soluble, which shapes how each gets into the body and into cells. Second, peptides are digested. Swallow most peptides and your stomach and small intestine treat them as food, cleaving them into amino acids before they reach circulation. That is why nearly every peptide PeRx prescribes is a subcutaneous injection, and why the oral exceptions (BPC-157 capsules, which act locally in the gut) are exceptions. Many oral anabolic steroids, by contrast, were deliberately modified at the 17-alpha position so they survive the liver, a modification that is also the reason for their liver toxicity.

Mechanism: Inside the Cell vs On the Surface

This is the distinction that explains almost every practical difference between the two classes, and it comes down to where the receptor sits.

Because steroids are lipids, they diffuse straight through the cell membrane. Inside, they bind the androgen receptor, and the steroid-receptor complex travels to the nucleus, attaches to DNA, and changes which genes the cell transcribes. The DEA describes it in one sentence: "Anabolic steroids bind to and activate androgen receptors in the body," with activation in various tissues mediating both the anabolic effects (skeletal muscle growth, bone density, red blood cell production) and the androgenic effects (male secondary sex characteristics). That is a slow, broad, genomic mechanism. It reaches every tissue that carries an androgen receptor, which is most of them, and it keeps acting for as long as the drug is around.

Peptides cannot do this. They are water-soluble and generally too large and polar to cross the membrane, so they act from the outside, docking on receptors embedded in the cell surface. Most of the peptides in a clinic's formulary work through G-protein-coupled receptors or similar surface receptors, which then pass the signal inward through second messengers. Ipamorelin binds the ghrelin receptor (GHS-R1a) on pituitary cells. Sermorelin, CJC-1295, and tesamorelin Explore PeRxTesamorelinMetabolic Optimization PeptideView peptide bind the GHRH receptor on the same cells. BPC-157's exact receptor is still not fully characterized, though the animal literature points to effects on growth factor receptor signaling and nitric oxide pathways (Sikiric et al., Current Pharmaceutical Design, 2018). None of them enter the nucleus and rewrite gene expression the way a steroid does.

Sikiric P et al. "Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing." Current Pharmaceutical Design, 2018. View study

Two things follow. Surface-receptor signaling is faster and shorter-lived, and it stays inside the body's own regulatory loops. When a GHRH analog triggers a growth hormone pulse, the resulting rise in IGF-1 feeds back on the pituitary and hypothalamus and dampens the next pulse, exactly as it does with the body's native GHRH. There is no equivalent brake on an injected steroid ester sitting in a muscle depot for two weeks.

Legal Classification in the US

The legal answer is where "peptides are not steroids" stops being a chemistry lesson and becomes a fact with consequences.

Anabolic steroids are controlled substances. The Anabolic Steroids Control Act of 1990, signed November 29, 1990 and effective February 27, 1991, placed them in Schedule III of the Controlled Substances Act alongside drugs like ketamine and buprenorphine. The Anabolic Steroid Control Act of 2004 (effective January 20, 2005) rewrote the statutory definition so that a substance is an anabolic steroid if it is chemically and pharmacologically related to testosterone, is not an estrogen, progestin, or corticosteroid, and is not DHEA. That change removed the earlier requirement that the government prove a substance promotes muscle growth before scheduling it, and it let the DEA add new designer steroids by rule. Possessing an anabolic steroid without a valid prescription is a federal crime; distributing one carries felony exposure.

Read that definition again and notice what it requires: chemical and pharmacological relation to testosterone. A chain of amino acids cannot satisfy it. No peptide is, or could be, scheduled under the anabolic steroid provisions, because the statute is written around a molecular family peptides do not belong to.

That does not make peptides unregulated, and this is the part vendors gloss over. As of August 2026, BPC-157, TB-500, ipamorelin, CJC-1295, MOTS-c Explore PeRxMOTS-cThe Mitochondrial PeptideView peptide , and most of the rest of the therapeutic peptide space are not FDA-approved drugs. Sermorelin and tesamorelin have approval histories (sermorelin's brand product was withdrawn for commercial reasons; tesamorelin remains approved under the brand Egrifta for one narrow indication). Under federal law, an unapproved drug can be prepared for an individual patient by a state-licensed compounding pharmacy under section 503A of the Food, Drug, and Cosmetic Act, against a prescription from a licensed provider. That is the pathway PeRx uses. Selling those same peptides directly to the public, with or without a "research use only" sticker, is selling an unapproved drug, and the FDA has been steadily more aggressive about it. The April 2026 FDA action removing several peptides from the Category 2 bulks list, and the July 2026 Pharmacy Compounding Advisory Committee vote (a non-binding recommendation that FDA has not finalized as of this writing), both live in that compounding framework, not in controlled-substance law. We keep a running account in are peptides legal in 2026 Read nextAre Peptides Legal in 2026? Regulatory StatusThe legal landscape for peptides has shifted more in the past two years than in the previous decade. Between FDA reclassifications, compounding pharmacy regulations, and state-level telehealth laws, the status of individual peptides changes frequently. Here is where things stand as of April 2026.Read article .

Are Peptides Anabolic? The GH Secretagogue Question

"Anabolic" just means building up tissue, and in that loose sense insulin, growth hormone, a protein shake, and sleep are all anabolic. The question people actually mean is narrower: do peptides do what anabolic steroids do to muscle? The honest answer is no, and the place where that answer needs the most care is the growth hormone secretagogues, because they are the peptides most often sold next to steroids and most often mistaken for a hormone drug.

There are three distinct things here, and gym vocabulary flattens them into one. Anabolic steroids are exogenous androgens: you inject a testosterone derivative and it acts directly on androgen receptors. Exogenous HGH (somatropin) is a recombinant copy of the 191-amino-acid growth hormone itself: you inject the hormone and it goes to work with no involvement from your pituitary, at whatever dose and rhythm you inject. Growth hormone secretagogues are neither. Sermorelin, CJC-1295, and tesamorelin are analogs of GHRH, the hypothalamic signal that tells the pituitary to release GH. Ipamorelin mimics ghrelin at a second pituitary receptor. Both routes cause your own pituitary to release its own growth hormone, in pulses, subject to the feedback loops that normally govern it.

A 2018 review in Sexual Medicine Reviews (Sigalos and Pastuszak) summarized the human data on this class: secretagogues raise GH and IGF-1 within physiologic ranges, preserve the pulsatile pattern of release, and have shown a more benign side-effect profile than exogenous GH in the trials that exist, with the caveat that long-term safety data in healthy adults are thin. That "within physiologic ranges" point is the whole distinction. A steroid or a supraphysiologic HGH dose pushes a hormone past what the body would produce; a secretagogue asks the pituitary to produce more of what it already makes and cannot force it past its ceiling. The comparison with somatropin specifically is laid out in sermorelin vs HGH Read nextSermorelin vs HGH: How They Really DifferBoth raise growth hormone, but they do it in opposite ways. Sermorelin is a GHRH analog that asks your own pituitary to release growth hormone in natural pulses, so your feedback control stays intact. Synthetic HGH is the finished hormone injected straight into circulation, which overrides that control. Here is the honest, mechanism-first comparison.Read article .

Sigalos JT, Pastuszak AW. "The Safety and Efficacy of Growth Hormone Secretagogues." Sexual Medicine Reviews, 2018. View study

None of this means secretagogues are a muscle-building shortcut, and we would rather you hear the limits from us. The human evidence for body-composition change with sermorelin or ipamorelin in healthy adults is modest and short-term, most of the enthusiastic numbers online come from small studies in deficient or older populations, and no peptide PeRx prescribes is indicated for muscle growth. If muscle is the goal, the evidence-based tools are still training, protein, and sleep; our muscle growth peptide guide Read nextMuscle Growth Peptides 2026: What Actually WorksPeptides are signaling tools, not muscle-building shortcuts. The useful clinical question isn't whether they build muscle. It's which pathway you're trying to influence, whether the effect is big enough to matter alongside training and nutrition, and whether you've matched the mechanism to the actual bottleneck.Read article goes through what the peptide literature does and does not support.

The healing peptides deserve their own line. BPC-157, TB-500, and GHK-Cu Explore PeRxGHK-CuThe Skin Rejuvenation PeptideView peptide are not anabolic in the hormonal sense at all. Nothing in the BPC-157 literature involves androgen receptors, sex hormones, or the GH axis; the proposed mechanisms are angiogenesis, growth factor receptor signaling, and nitric oxide modulation, and nearly all of it is animal data (Seiwerth et al., Current Pharmaceutical Design, 2018). If someone tells you BPC-157 Read nextBPC-157 Peptide: Benefits, Dosage & Complete GuideA peptide discovered in a Croatian lab in the early '90s is now one of the most studied healing compounds in regenerative medicine. Here's what the science actually says, where it came from, and what you should know before starting.Read article is "basically a steroid for tendons," they are describing a hoped-for outcome, not a mechanism.

Seiwerth S et al. "BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing." Current Pharmaceutical Design, 2018. View study

Side-Effect Profiles Compared

The side-effect contrast is a direct consequence of the mechanism contrast. Steroids act everywhere androgen receptors exist and override the body's own hormone production. Peptides act on specific surface receptors inside intact feedback loops. So the two lists look nothing alike.

The Endocrine Society's 2014 scientific statement on performance-enhancing drugs (Pope et al., Endocrine Reviews) catalogues what happens with anabolic-androgenic steroid use at the doses people actually take, often 10 to 100 times a therapeutic dose according to DEA: suppression of the hypothalamic-pituitary-testicular axis with testicular shrinkage and infertility that can persist for months or longer after stopping; gynecomastia; erythrocytosis; adverse lipid changes and evidence of cardiomyopathy and accelerated coronary disease with long-term use; hepatotoxicity with oral 17-alpha-alkylated compounds; virilization in women that is partly irreversible; premature growth-plate closure in adolescents; and a recognized dependence syndrome with withdrawal depression. The DEA fact sheet lists essentially the same set.

Pope HG Jr, Wood RI, Rogol A, et al. "Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement." Endocrine Reviews, 2014. View study

The peptide list is shorter and, for most compounds, less well characterized, which is a different kind of concern. For GH secretagogues the reported effects are injection-site reactions, flushing, headache, transient water retention, and with ipamorelin a short-lived hunger spike after dosing; in the trials Sigalos and Pastuszak reviewed, secretagogues did not produce the glucose intolerance, joint swelling, or carpal tunnel symptoms associated with exogenous GH, though longer-term data are limited. For BPC-157, human safety data barely exist; the animal studies report little toxicity, and clinic experience is mostly injection-site irritation, but "no reported problems in rodents" is not the same as a human safety record, and the FDA cited exactly this gap when it acted on BPC-157 in 2026. Nothing in either list involves shutting down your own hormone production.

Drug Tests and Tested Sport

Two separate questions hide inside "will peptides show up on a drug test," and they have opposite answers.

For a standard drug screen, the kind used for employment, DOT, probation, or a pre-surgical panel, the answer is no. Those panels are immunoassays for drugs of abuse: amphetamines, cannabinoids, cocaine metabolites, opioids, PCP, and on expanded panels benzodiazepines, barbiturates, and a few others. They do not test for peptides, and they do not test for anabolic steroids either; steroid testing is a separate, mass-spectrometry-based panel that almost no employer orders. Peptides also do not cross-react with the antibodies in those assays. The detection windows and the panel details are in do peptides show up on a drug test Read nextDo Peptides Show Up on a Drug Test?The short answer for most people is no. Standard employment and DOT drug screens do not test for therapeutic peptides. Anti-doping testing in competitive sport is a separate system with dedicated peptide detection, and that is where the answer changes. Here is the honest, clinic-side breakdown of who is tested, for what, and what it means if you are prescribed peptides.Read article .

For anti-doping testing, the answer flips, and this is where "peptides are not steroids" can get an athlete into trouble. WADA does not organize its Prohibited List by molecule type; it organizes by effect and approval status. Steroids sit under S1 (Anabolic Agents). Peptides land in several other sections. As of the 2026 List, in force since January 1, 2026:

BPC-157 is prohibited at all times under S0, Non-Approved Substances, the catch-all for any pharmacological substance with no current approval from a governmental health authority for human use. USADA has published a specific advisory saying so. TB-500 is prohibited under S2 as a thymosin beta-4 derivative, listed among growth factors and growth factor modulators since 2012. Sermorelin, tesamorelin, and CJC-1295 are prohibited under S2 as GHRH analogs; ipamorelin is prohibited under S2 as a growth hormone secretagogue, alongside GHRP-2, GHRP-6, and MK-677. MOTS-c is prohibited at all times under S4.4, metabolic modulators, as an activator of AMP-activated protein kinase, per USADA guidance on the current List. All of these apply in and out of competition, and anti-doping laboratories have validated mass-spectrometry methods for the GHRH analogs and secretagogues specifically.

A drug-tested athlete should treat every peptide as prohibited until Global DRO (the searchable database run jointly by USADA, UK Anti-Doping, and partner agencies) or their federation says otherwise, and should know that a Therapeutic Use Exemption for an unapproved drug is very unlikely to be granted. Sanctions can also be non-analytical: possession, purchase records, or an admission can be enough without a positive test. Peptides are not steroids, but WADA prohibits both, and it does not care about the chemistry distinction this article spends most of its length on. The same logic applies to SARMs, which are a third category again; peptides vs SARMs Read nextPeptides vs SARMs: The Difference and Why It MattersThey get lumped together in the same forum threads, but peptides and SARMs are not the same category. One is a class of signaling molecules. The other is a class of synthetic androgen-receptor drugs the FDA has flagged for serious harm. The more useful line, though, is not peptide vs SARM. It is prescribed and tested vs unregulated. Here is the honest comparison.Read article covers that comparison.

USADA. "BPC-157: Experimental Peptide Creates Risk for Athletes." Athlete advisory confirming S0 prohibited status. View study

Why the Confusion Exists

If the chemistry is this clear, why does the question get searched more than ten thousand times a month? Because most people meet peptides in an environment built by and for steroid users.

Growth hormone secretagogues were adopted by bodybuilders in the 2000s, partly as a cheaper substitute for HGH and partly as something to run during "post-cycle therapy" after steroids. Forum vocabulary carried over wholesale: people "cycle" BPC-157, "stack" ipamorelin, and post "before and after" threads in the same subforum as their trenbolone logs. The "research chemical" vendors that grew up to serve that market sell peptides, SARMs, and steroid precursors on the same page, in the same vials, with the same "not for human consumption" label. When two products share a shelf, a shopping cart, and a slang dictionary, it is natural to assume they share a pharmacology.

The FDA's 2023 and 2026 actions on peptides added a second layer. News coverage often lumped "BPC-157" and "anabolic steroids" into one sentence about gray-market injectables, and a reader who skims comes away with the impression that regulators treat them as the same kind of thing. They do not; as the legal section above explains, they are regulated under different statutes by different agencies, and the peptide enforcement is about unapproved drugs and compounding, not controlled substances.

From the clinic side, this confusion shows up at intake in a few predictable forms. The most common is a patient who is nervous about a peptide prescription because a friend told them it would "shut down their natural testosterone"; it will not, because nothing in the formulary touches the testicular axis. The second is a patient who assumes that because they take a peptide they can skip the "steroids" disclosure box on a medical history form, which is correct, and who then assumes the same about an anti-doping declaration, which is not. The third, and the one worth naming, is the occasional patient who hopes a peptide will do what a steroid does and wants a provider to confirm it. The truthful answer is that it will not, and a clinic that promises otherwise is selling you the gym-forum story rather than the pharmacology.

Peptides are a different tool with a different evidence base, most of which is still early. Understanding that they are not steroids is the first step toward using them for what the data actually support. For how a legitimate prescription works from intake to delivery, see how to get peptides prescribed online Read nextHow to Get Peptides Prescribed OnlineThere is a legitimate way to get peptides prescribed through telehealth, and there is a gray market that skips the medicine entirely. This guide walks the real path step by step: the online assessment, the licensed provider who reviews it, the US compounding pharmacy that prepares your peptide, and the box that arrives ready to use. It also shows you how to spot the sites you should walk away from.Read article .

Common Questions